Colonic manifestations of PTEN hamartoma tumor syndrome: Case series and systematic review

被引:40
|
作者
Stanich, Peter P. [1 ]
Pilarski, Robert [2 ]
Rock, Jonathan [3 ]
Frankel, Wendy L. [3 ]
El-Dika, Samer [1 ]
Meyer, Marty M. [1 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Div Gastroenterol Hepatol & Nutr, Columbus, OH 43210 USA
[2] Ohio State Univ, Wexner Med Ctr, Div Human Genet, Columbus, OH 43210 USA
[3] Ohio State Univ, Wexner Med Ctr, Dept Pathol, Columbus, OH 43210 USA
关键词
Adenoma; Bannayan-Riley-Ruvalcaba syndrome; Colon polyps; Colorectal cancer; Cowden syndrome; Endoscopy; Ganglioneuroma; Hamartoma; Hyperplastic; Phosphatase and tensin homolog on chromosome ten; GENOTYPE-PHENOTYPE CORRELATIONS; LHERMITTE-DUCLOS-DISEASE; COWDEN-SYNDROME; GERMLINE MUTATIONS; GENE-MUTATIONS; POLYPOSIS; CANCER; CLASSIFICATION; INDIVIDUALS; SPECTRUM;
D O I
10.3748/wjg.v20.i7.1833
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate our clinical experience with the colonic manifestations of phosphatase and tensin homolog on chromosome ten (PTEN) hamartoma tumor syndrome (PHTS) and to perform a systematic literature review regarding the same. METHODS: This study was approved by the appropriate institutional review board prior to initiation. A clinical genetics database was searched for patients with PHTS or a component syndrome that received gastrointestinal endoscopy or pathology interpretation at our center. These patient's records were retrospectively reviewed for clinical characteristics (including family history and genetic testing), endoscopy results and pathology findings. We also performed a systematic review of the literature for case series of PHTS or component syndromes that reported gastrointestinal manifestations and investigations published after consensus diagnostic criteria were established in 1996. These results were compiled and reported. RESULTS: Eight patients from our institution met initial inclusion criteria. Of these, 5 patients underwent 4.2 colonoscopies at mean age 45.8 +/- 10.8 years. All were found to have colon polyps during their clinical course and polyp histology included adenoma, hyperplastic, ganglioneuroma and juvenile. No malignant lesions were identified. Two had multiple histologic types. One patient underwent colectomy due to innumerable polyps and concern for future malignant potential. Systematic literature review of PHTS patients undergoing endoscopy revealed 107 patients receiving colonoscopy at mean age 37.4 years. Colon polyps were noted in 92.5% and multiple colon polyp histologies were reported in 53.6%. Common polyp histologies included hyperplastic (43.6%), adenoma (40.4%), hamartoma (38.3%), ganglioneuroma (33%) and inflammatory (24.5%) polyps. Twelve (11.2%) patients had colorectal cancer at mean age 46.7 years (range 35-62). Clinical outcomes secondary to colon polyposis and malignancy were not commonly reported. CONCLUSION: PHTS has a high prevalence of colon polyposis with multiple histologic types. It should be considered a mixed polyposis syndrome. Systematic review found an increased prevalence of colorectal cancer and we recommend initiating colonoscopy for colorectal cancer surveillance at age 35 years. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
引用
收藏
页码:1833 / 1838
页数:6
相关论文
共 50 条
  • [1] Colonic manifestations of PTEN hamartoma tumor syndrome: Case series and systematic review
    Peter P Stanich
    Robert Pilarski
    Jonathan Rock
    Wendy L Frankel
    Samer El-Dika
    Marty M Meyer
    World Journal of Gastroenterology, 2014, (07) : 1833 - 1838
  • [2] Gastrointestinal manifestations in PTEN hamartoma tumor syndrome
    D'Ermo, Giuseppe
    Genuardi, Maurizio
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2022, 58-59
  • [3] PTEN hamartoma tumor syndrome: An overview
    Hobert, Judith A.
    Eng, Charis
    GENETICS IN MEDICINE, 2009, 11 (10) : 687 - 694
  • [4] PTEN Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular Pathogenesis
    Innella, Giovanni
    Bonora, Elena
    Neri, Iria
    Virdi, Annalucia
    Guglielmo, Alba
    Pradella, Laura Maria
    Ceccarelli, Claudio
    Amato, Laura Benedetta
    Lanzoni, Anna
    Miccoli, Sara
    Gasparre, Giuseppe
    Zuntini, Roberta
    Turchetti, Daniela
    FRONTIERS IN MEDICINE, 2021, 8
  • [5] PTEN Hamartoma tumor syndrome in childhood: A review of the clinical literature
    Macken, William L.
    Tischkowitz, Marc
    Lachlan, Katherine L.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2019, 181 (04) : 591 - 610
  • [6] Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients
    Pena-Couso, Laura
    Ercibengoa, Maria
    Mercadillo, Fatima
    Gomez-Sanchez, David
    Inglada-Perez, Lucia
    Santos, Maria
    Lanillos, Javier
    Gutierrez-Abad, David
    Hernandez, Almudena
    Carbonell, Pablo
    Leton, Rocio
    Robledo, Mercedes
    Rodriguez-Antona, Cristina
    Perea, Jose
    Urioste, Miguel
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [7] Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome
    Mester, Jessica
    Eng, Charis
    GENETICS IN MEDICINE, 2012, 14 (09) : 819 - 822
  • [8] PTEN Hamartoma Tumor Syndrome and Immune Dysregulation
    Eissing, Marc
    Ripken, Lise
    Schreibelt, Gerty
    Westdorp, Harm
    Ligtenberg, Marjohjn
    Netea-Maier, Romana
    Netea, Mihai G.
    de Vries, I. Jolanda M.
    Hoogerbrugge, Nicoline
    TRANSLATIONAL ONCOLOGY, 2019, 12 (02): : 361 - 367
  • [9] PTEN Hamartoma Tumor Syndrome: A Clinical Overview
    Pilarski, Robert
    CANCERS, 2019, 11 (06)
  • [10] Neuroblastoma and cutaneous angiosarcoma in a child with PTEN hamartoma tumor syndrome
    Leibowitz, Michael S.
    Zelley, Kristin
    Adams, Denise
    Brodeur, Garrett M.
    Fox, Elizabeth
    Li, Marilyn M.
    Mattei, Peter
    Pogoriler, Jennifer
    MacFarland, Suzanne P.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (10)